HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the ...

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against ...

BriaCell patients treated since 2022 remain alive >18-47 months post enrollment, markedly exceeding benchmarks reported for standard ...

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...

But is the combination a "viable alternative" to nivolumab and ipilimumab?

People living with metastatic breast cancer have more treatment options today than ever before. At Fred Hutch Cancer Center, we provide the latest in evidence-based care, including a wide range of ...

PRESS RELEASEAB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE ...

How to know when it's time to get checked, brought to you by the editors of Verywell Health ljubaphoto / Getty Images Metastatic breast cancer occurs when breast cancer cells move into other parts of ...

Reinforces Synergistic Potential and Expands Opportunity Beyond Ovarian Cancer VANCOUVER, BC - January 29, 2026 (NEWMEDIAWIRE ...

The investigational GSK-3-beta inhibitor elraglusib can extend overall survival when added to standard first-line ...